Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.42 USD | -2.06% | -0.97% | +6.49% |
Apr. 23 | MetLife Increases Quarterly Dividend to $0.545 Per Share From $0.52, Payable June 11 to Shareholders of Record on May 7 | MT |
Apr. 23 | MetLife Raises Quarterly Dividend by 4.8% | DJ |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- One of the major weak points of the company is its financial situation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.49% | 50.92B | B+ | ||
+1.35% | 48.11B | B | ||
+9.53% | 42.2B | B+ | ||
+6.55% | 39.71B | B+ | ||
+19.34% | 37.78B | B | ||
+2.84% | 30.07B | B | ||
-7.77% | 27.56B | B- | ||
-18.42% | 24.71B | A- | ||
+6.89% | 21.99B | A | ||
+20.69% | 21.68B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MET Stock
- Ratings MetLife, Inc.